Vascular Endothelial Growth Factor Gene Variation and the Response to Photodynamic Therapy in Age-Related Macular Degeneration

Ophthalmology

Volumn 117, Issue 1, 2010, Pages 103-108

  Immonen, Ilkka ^a   Seitsonen, Sanna ^a   Tommila, Petri ^a   Kangas Kontio, Tiia ^b   Kakko, Sakari ^b   Savolainen, Eeva Riitta ^c   Savolainen, Markku J ^b   Liinamaa, M Johanna ^b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DNA POLYMORPHISM; FLUORESCENCE ANGIOGRAPHY; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROMOTER REGION; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME;

FLUORESCEIN ANGIOGRAPHY; GENOTYPE; HUMANS; MACULAR DEGENERATION; PHOTOCHEMOTHERAPY; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 72749095160     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.06.037     Document Type: Article

References (25)

1. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 22 (2004) 598-614
2. Swaroop A., Branham K.E., Chen W., and Abecasis G. Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum Mol Genet 16 (2007) R174-R182
3. Lafaut B.A., Bartz-Schmidt K.U., Vanden Broecke C., et al. Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation. Br J Ophthalmol 84 (2000) 239-243
4. Tammela T., Enholm B., Alitalo K., and Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 65 (2005) 550-563
5. Kvanta A., Algvere P.V., Berglin L., and Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37 (1996) 1929-1934
6. Bhatnagar P., Spaide R.F., Takahashi B.S., et al. Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 27 (2007) 846-850
7. Renner W., Kotschan S., Hoffmann C., et al. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37 (2000) 443-448
8. Perrin R.M., Konopatskaya O., Qiu Y., et al. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia 48 (2005) 2422-2427
9. Krippl P., Langsenlehner U., Renner W., et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106 (2003) 468-471
10. Churchill A.J., Carter J.G., Lovell H.C., et al. VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet 15 (2006) 2955-2961
11. Seitsonen S.P., Jarvela I.E., Meri S., et al. The effect of complement factor H Y402H polymorphism on the outcome of photodynamic therapy in age-related macular degeneration. Eur J Ophthalmol 17 (2007) 943-949
12. Seitsonen S., Järvelä I., Meri S., et al. Complement factor Y402H polymorphism and characteristics of exudative age-related macular degeneration. Acta Ophthalmol 86 (2008) 390-394
13. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report 1. Arch Ophthalmol 117 (1999) 1329-1345
14. International HapMap Consortium. The International HapMap Project. Nature 426 (2003) 789-796
15. Shahbazi M., Fryer A.A., Pravica V., et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13 (2002) 260-264
16. Koukourakis M.I., Papazoglou D., Giatromanolaki A., et al. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46 (2004) 293-298
17. Seitsonen S., Lemmela S., Holopainen J., et al. Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population. Mol Vis [serial online] 12 (2006) 796-801. http://www.molvis.org/molvis/v12/a89/ Accessed May 15, 2009
18. Tregouet D.A., Barbaux S., Escolano S., et al. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 11 (2002) 2015-2023
19. Tregouet D.A., and Tiret L. Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm. Eur J Hum Genet 12 (2004) 971-974
20. Tregouet D.A., Escolano S., Tiret L., et al. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 68 (2004) 165-177
21. Haines J.L., Schnetz-Boutaud N., Schmidt S., et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 47 (2006) 329-335
22. Riusala A.M., and Immonen I.J. Predictors of structural findings in old disciform lesions. Am J Ophthalmol 138 (2004) 245-253
23. Schmidt-Erfurth U., Schlotzer-Schrehard U., Cursiefen C., et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44 (2003) 4473-4480
24. Wachtlin J., Stroux A., Wehner A., et al. Photodynamic therapy with verteporfin for choroidal neovascularisations in clinical routine outside the TAP Study: one- and two-year results including juxtafoveal and extrafoveal CNV. Graefes Arch Clin Exp Ophthalmol 243 (2005) 438-445
25. Axer-Siegel R., Ehrlich R., Yassur Y., et al. Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns. Am J Ophthalmol 136 (2004) 258-264